U.S. Markets open in 24 hrs, 48 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 0.84 03:59 PM EST | |
|---|---|---|
| Day High | 0.90 09:30 AM EST |
|
| Range | 0.06 |
| Volume | 104,340 | |
|---|---|---|
| 30-Day Avg Vol | 183,000 |
|
| Difference | -42.98% |
| Market Cap | 20.76 M | |
|---|---|---|
| Mkt Cap Chg | -977,325 |
| Shares Out | 24.43 M | |
|---|---|---|
| % Shrs Traded | 0.43% | |
| 1yr EPS Est | -0.655 |
| 52-Wk Low | 0.23 | |
|---|---|---|
| 52-Wk High | 1.66 |
|
| Range | 1.43 |
| Prev Close | 0.89 11/5/09 | |
|---|---|---|
| Today's Open | 0.90 | |
| Change | 1.12% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 40,719.00 |
| Revenue (LFY) | 877,000 | |
|---|---|---|
| Earnings (LFY) | -40.39 M | |
| Earnings (MRQ) | -3.12 M | |
| Next Earn Est | -0.165 | |
| Next Earnings | 03/29/2010 |
|
| EPS (TTM) | -1.10 | |
| 1yr EPS Growth | 40.99% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -1.00 | |
| PEG Ratio | — | |
| Return on Equity | -217.14 | |
| Beta | 2.52 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Cyclacel has found a new reason to be excited. Formerly Xcyte Therapies, the company acquired Cyclacel Group in a reverse merger early in 2006. As part of the transaction, Xcyte sold its primary technology ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.165 11/3/09 | — — |
—
—
|
| Last Quarter | -0.22 9/30/09 | -0.13 9/30/09 |
0.09
Beat
|
| 2 Quarters Ago | -0.255 6/30/09 | -0.34 6/30/09 |
-0.085
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 230,000.00 | 877,000.00 |
| Gross Profit | 67,000.00 | -1.41 M |
| Operating Income | -3.52 M | -33.78 M |
| Net Income | -3.12 M | -40.39 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts